Reply to Morice and Hart: Increased Propensity for Pneumonia with Fluticasone in Chronic Obstructive Pulmonary Disease.

Lipson, David A; Barnacle, Helen; Birk, Ruby; Brealey, Noushin; Locantore, Nicholas; Lomas, David A; Ludwig-Sengpiel, Andrea; Mohindra, Rajat; Tabberer, Maggie; Zhu, Chang-Qing; Pascoe, Steven J

Lipson, David A; Barnacle, Helen; Birk, Ruby; Brealey, Noushin; Locantore, Nicholas; Lomas, David A; Ludwig-Sengpiel, Andrea; Mohindra, Rajat; Tabberer, Maggie; Zhu, Chang-Qing; Pascoe, Steven J.

Afiliação

Lipson DA; 1 GSK King of Prussia, Pennsylvania.
Barnacle H; 2 University of Pennsylvania Philadelphia, Pennsylvania.
Birk R; 3 GSK Uxbridge, United Kingdom.
Brealey N; 3 GSK Uxbridge, United Kingdom.
Locantore N; 3 GSK Uxbridge, United Kingdom.
Lomas DA; 1 GSK King of Prussia, Pennsylvania.
Ludwig-Sengpiel A; 4 University College London London, United Kingdom and.
Mohindra R; 5 KLB Health Research Lübeck, Germany.
Tabberer M; 3 GSK Uxbridge, United Kingdom.
Zhu CQ; 3 GSK Uxbridge, United Kingdom.
Pascoe SJ; 3 GSK Uxbridge, United Kingdom.

Am J Respir Crit Care Med ; 197(9): 1230-1231, 2018 05 01.

Article em En | MEDLINE | ID: mdl-29241016

Assuntos

Pneumonia; Doença Pulmonar Obstrutiva Crônica; Broncodilatadores; Fluticasona; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pneumonia / Doença Pulmonar Obstrutiva Crônica Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google